Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Aliberti S, Ringshausen FC, Dhar R, Haworth CS, Loebinger MR, Dimakou K, Crichton ML, De Soyza A, Vendrell M, Burgel PR, McDonnell M, Skrgat S, Maiz Carro L, de Roux A, Sibila O, Bossios A, van der Eerden M, Kauppi P, Wilson R, Milenkovic B, Menendez R, Murris M, Borekci S, Munteanu O, Obradovic D, Nowinski A, Amorim A, Torres A, Lorent N, Van Braeckel E, Altenburg J, Shoemark A, Shteinberg M, Boersma W, Goeminne PC, Elborn JS, Hill AT, Welte T, Blasi F, Polverino E, Chalmers JD; EMBARC Registry Investigators.
Eur Respir J. 2024 Apr 18;63(4):2301554. doi: 10.1183/13993003.01554-2023. Print 2024 Apr.
Sputum handling for rheology.
Esteban Enjuto L, Robert de Saint Vincent M, Maurin M, Degano B, Bodiguel H.
Sci Rep. 2023 May 11;13(1):7695. doi: 10.1038/s41598-023-34043-9.
Identification rate of Legionella species in non-purulent sputum culture is comparable to that in purulent sputum culture in Legionella pneumonia.
Ito A, Ishida T, Tachibana H, Nakanishi Y, Kawataki M, Yamazaki A, Washio Y.
J Clin Microbiol. 2024 Apr 10;62(4):e0166523. doi: 10.1128/jcm.01665-23. Epub 2024 Mar 19.
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.
Hill AT, Haworth CS, Aliberti S, Barker A, Blasi F, Boersma W, Chalmers JD, De Soyza A, Dimakou K, Elborn JS, Feldman C, Flume P, Goeminne PC, Loebinger MR, Menendez R, Morgan L, Murris M, Polverino E, Quittner A, Ringshausen FC, Tino G, Torres A, Vendrell M, Welte T, Wilson R, Wong C, O'Donnell A, Aksamit T; EMBARC/BRR definitions working group.
Eur Respir J. 2017 Jun 8;49(6):1700051. doi: 10.1183/13993003.00051-2017. Print 2017 Jun.
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA.
Ann Intern Med. 1987 Feb;106(2):196-204. doi: 10.7326/0003-4819-106-2-196.
Bronchiectasis.
ten Hacken N, Kerstjens H, Postma D.
BMJ Clin Evid. 2008 Jan 2;2008:1507.
Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease.
Manjhi R, Nanda SK, Agrawal BK.
J Family Med Prim Care. 2022 Dec;11(12):7713-7719. doi: 10.4103/jfmpc.jfmpc_576_22. Epub 2023 Jan 17.
Addition of a bacterial alginate lyase to purulent CF sputum in vitro can result in the disruption of alginate and modification of sputum viscoelasticity.
Mrsny RJ, Lazazzera BA, Daugherty AL, Schiller NL, Patapoff TW.
Pulm Pharmacol. 1994 Dec;7(6):357-66. doi: 10.1006/pulp.1994.1042.
A Systematic Review and Meta-Analysis of Sputum Purulence to Predict Bacterial Infection in COPD Exacerbations.
Chen K, Pleasants KA, Pleasants RA, Beiko T, Washburn RG, Yu Z, Zhai S, Drummond MB.
COPD. 2020 Jun;17(3):311-317. doi: 10.1080/15412555.2020.1766433. Epub 2020 May 27.
Most of the lipid in purulent sputum is bound to mucus glycoprotein.
Nadziejko CE, Slomiany BL, Slomiany A.
Exp Lung Res. 1993 Nov-Dec;19(6):671-84. doi: 10.3109/01902149309064364.
